Critics on social media sounded the alarm after comments from Pete Hegseth in a preview of an upcoming interview on “60 Minutes” began circulating online FridayCritics on social media sounded the alarm after comments from Pete Hegseth in a preview of an upcoming interview on “60 Minutes” began circulating online Friday

Hegseth triggers massive alarms with 'grotesque' Iran remark in new '60 Minutes' clip

2026/03/07 10:42
2 min read
For feedback or concerns regarding this content, please contact us at [email protected]

Critics on social media sounded the alarm after comments from Pete Hegseth in a preview of an upcoming interview on “60 Minutes” began circulating online Friday.

In the clip, Hegseth was asked about reports that Russia is assisting Iran in targeting Americans and whether that would place U.S. personnel in greater danger.

“No one’s putting us in danger,” Hegseth replied in the interview, set to air Sunday. “We’re putting the other guys in danger. That’s our job. So we’re not concerned about that.”

He then added a line that quickly drew criticism online.

“The only ones that need to be worried right now are Iranians that think they're going to live,” Hegseth said.

The comment prompted backlash from political commentators and policy analysts.

Writer and commentator Adam Schwarz called the remark “a grotesquely indiscriminate threat against the entire Iranian population.”

“Hegseth's statements are increasingly reminding me of comments by Israeli government leaders in the early stages [of] the Gaza War - comments that are now being reviewed by the International Court of Justice,” he added on X.

Other critics launched harsher jabs.

Stan Oklobdzija, associate professor of public policy at the University of California, Riverside, wrote on Bluesky: “It's ok to hate the people who voted for this.”

Journalist Laura Jedeed also mocked the remark, telling her Bluesky followers that Hegseth was targeting “Not ‘terrorists,’ not ‘radicals,’ not even ‘Islamists.’ ‘Iranians.’ In case anyone was confused about who the enemy is.” She added that the statement came from “Pete Hegseth, Very Normal Guy.”

“Take that, Iranian kids,” Atheist blogger Hemant Mehta posted on X. “He’s coming after your schools next.”

MS NOW host Chris Hayes told his Bluesky followers, "Worth watching the whole clip, but purely in propaganda terms it seems to me, admittedly just an amateur observer when it comes to war fighting, that it may be useful to send the message to the 91+ million Iranian civilians that we are not trying to kill them."

Journalist Justin Baragona was even more blunt.

"We live in a world where the binge-drinking Fox News weekend host who didn't wash his hands for a decade is openly boasting about committing genocide," he wrote on Bluesky.

Market Opportunity
Notcoin Logo
Notcoin Price(NOT)
$0.0003691
$0.0003691$0.0003691
+2.49%
USD
Notcoin (NOT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09